Pharming Group N.V. (PHAR) Revenue 2019–2025
Pharming Group N.V. (PHAR) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$376.1MFY2025 · since FY2019: $189.4M → $376.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $376.1M | +26.6% |
| FY2024 | $297.2M | +21.1% |
| FY2023 | $245.3M | +19.3% |
| FY2022 | $205.6M | +3.4% |
| FY2021 | $198.9M | -6.3% |
| FY2020 | $212.2M | +12.0% |
| FY2019 | $189.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PHAR financial trends
PHAR Net incomePHAR Net marginPHAR Gross profitPHAR Gross marginPHAR Operating incomePHAR Operating marginPHAR Operating cash flowPHAR Free cash flowPHAR Capital expendituresPHAR Return on equityPHAR Stock buybacksPHAR Dividends paidPHAR Total assetsPHAR Total liabilitiesPHAR Shareholders’ equityPHAR overview →